Class IIIOngoing

Diclofenac Sodium Topical Gel recall

FDA recall D-0291-2026 · initiated Dec 22, 2025

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Why it was recalled

Failed PH Specifications

Details

Product: Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
Recalling company: Cipla Limited
Classification: Class III
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide in the USA
Initiated: Dec 22, 2025
FDA report date: Jan 28, 2026

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0291-2026 ↗

← All drug recalls